Osteoarthritis, hip arthritis, avascular necrosis of the femoral head, developmental dysplasia of the hip (DDH)
Conditions
Interventions
Experimental group:In the experimental group, buprenorphine patch was applied at night before operation
Control group:The self-adhesive surgical dressing was trimmed to buprenorphine patch form as placebo (buprenorphine patch odorless) and also applied to the patient
Sponsors
Qilu Hospital of Shandong University
Eligibility
Sex/Gender
All
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Elective, primary total knee arthroplasty (TKA) and total hip arthroplasty (THA); 2.Age >= 60 years;
Exclusion criteria
Exclusion criteria: 1.Bilateral surgery; 2.Allergy to buprenorphine; 3.Severe hepatic or renal insufficiency, or poor overall physical tolerance; 4.Severe psychiatric disorders or cognitive impairment, making it impossible to understand or cooperate with treatment; 5.Patients with diseases or on medications that may affect study outcomes (e.g., psychiatric disorders, opioid abuse, insomnia, or use of prescription sleep aids);
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of sleep disorders at 7 days postoperatively; | — |
Secondary
| Measure | Time frame |
|---|---|
| Self-assessment of patient anxiety levels.;Prevalence of sleep disturbances 14 days post-surgery.;VAS pain scores for rest and activity after surgery, ranging from 1 to 14 days.;Temporary increases in the frequency of pain medication during hospitalization, as well as complications encountered.; | — |
Countries
China
Contacts
Public ContactQunshan Lu
Qilu Hospital of Shandong University
Outcome results
None listed